Treatment modification after starting cART in people living with HIV: retrospective analysis of the German ClinSurv HIV Cohort 2005–2017

  • Objective: Combination antiretroviral therapy (cART) has markedly increased survival and quality of life in people living with HIV. With the advent of new treatment options, including single-tablet regimens, durability and efficacy of first-line cART regimens are evolving. Methods: We analyzed data from the prospective multicenter German Clinical Surveillance of HIV Disease (ClinSurv) cohort of the Robert-Koch Institute. Kaplan–Meier and Cox proportional hazards models were run to examine the factors associated with treatment modification. Recovery after treatment initiation was analyzed comparing pre-cART viral load and CD4+ T-cell counts with follow-up data. Results: We included 8788 patients who initiated cART between 2005 and 2017. The sample population was predominantly male (n = 7040; 80.1%), of whom 4470 (63.5%) were reporting sex with men as the transmission risk factor. Overall, 4210 (47.9%) patients modified their first-line cART after a median time of 63 months (IQR 59–66). Regimens containing integrase strand transfer inhibitors (INSTI) were associated with significantly lower rates of treatment modification (adjusted hazard ratio 0.44; 95% CI 0.39–0.50) compared to protease inhibitor (PI)-based regimens. We found a decreased durability of first-line cART significantly associated with being female, a low CD4+ T-cell count, cART initiation in the later period (2011–2017), being on a multi-tablet regimen (MTR). Conclusions: Drug class and MTRs are significantly associated with treatment modification. INSTI-based regimens showed to be superior compared to PI-based regimens in terms of durability.

Export metadata

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:Melanie StecherORCiDGND, Philipp Frederik SchommersORCiDGND, Christian Kollan, Matthias Stoll, Frieder Kuhlendahl, Hans‑Jürgen Stellbrink, Jan‑Christian Wasmuth, Christoph StephanORCiDGND, Laura Hamacher, Clara Lehmann, Christoph Boesecke, Johannes Bogner, Stefan Esser, Carlos Fritzsche, Annette Haberl, Christian Hofmann, Björn Jensen, Carolynne Schwarze‑Zander, Martin Platten, Gerd FätkenheuerORCiDGND, Daniel Schmidt, Barbara Gunsenheimer-Bartmeyer, Jörg Janne VehreschildORCiDGND
URN:urn:nbn:de:hebis:30:3-574586
DOI:https://doi.org/10.1007/s15010-020-01469-6
ISSN:1439-0973
ISSN:0300-8126
Parent Title (English):Infection
Publisher:Springer
Place of publication:Heidelberg ; Berlin
Document Type:Article
Language:English
Year of Completion:2020
Year of first Publication:2020
Publishing Institution:Universitätsbibliothek Johann Christian Senckenberg
Contributing Corporation:ClinSurv Study Group
Release Date:2021/02/10
Tag:First-line regimen; HIV; Treatment modification; cART
Volume:48
Page Number:11
First Page:723
Last Page:733
Institutes:Medizin / Medizin
Dewey Decimal Classification:6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License LogoCreative Commons - Namensnennung 4.0